Splenic hemangiosarcoma
clinical study (dogs).

Location: Midvale, UT

Study details.

This is a collaborative study with Animal Medical Center in New York, NY. It’s a prospective, randomized, double-blinded, clinical study with active control, intended to compare the effects of two drug therapies (doxorubicin paired with immunotherapy vs. doxorubicin paired with placebo) on the progression free survival time of canine hemangiosarcoma patients after splenectomy. Morbidity and mortality will be compared between treatment groups.

Study financial benefits.

Study eligibility and commitment.

Dogs are NOT eligible if they…

Midvale participation.

Contact Dr. Katherine Wright, DVM, DACVIM (Oncology) at (813) 871-0600.